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Both 1,25-dihydroxyvitamin D 3 (VD) and retinoids 
have potent effects on keratinocyte proliferation. 
Parallelism in their action as steroid hormones, 
which involves interaction of their receptors, and in 
their therapeutic efficacy for hyper-proliferative skin 
diseases provides a rationale to investigate their com-
bined action on proliferation in pre-confluent hu-
man epidermal keratinocyte cultures. As shown by 
CHJthymidine incorporation, all-trans retinoic acid 
(atRA) at subpharmacologic concentrations and 9-cis 
retinoic acid (9cRA) diminished the anti-proliferative 
effect of VD. Pre-incubation of the cells with the 
retinoids clearly enhanced this effect. Cell-cycle 
analysis revealed Gl arrest upon VD treatment that 
was attenuated by retinoic acid (RA). Moreover, 
Northern and Western blot analysis demonstrated 
1 ,25-dihydJ:oxyvitamin D 3 (VD) and alJ-trnus retinoic acid (atRA) are the natural, biologically active forms of vitamin D 3 and vitamin A. They f:imction in an auto-crine, paracrine, or endocdne manner and exert their e fFects mainly through their intracellular receptors, reti-
noic acid receptors (RARs) and v.itamin D receptor (VDR) (Kang 
et a/ , 1996), which belong to the nuclear receptor superfamily 
(Man gelsdorf et a/, 1995) . These receptors function as ligand-
activated transcription factors th<lt bind to specific DNA sequences 
(the so-call ed hormone response elements) in the promoter region 
of targe t genes (Haussler et al, 1995). For cfricient binding to most 
vitamin D response elements and retinoic acid response elements 
(and for subsequent transcrip tional regul ation), VDR and RAR 
muse heterodim erize with an auxi liary factor, the retinoid X 
receptor (RXJt) (Kliewer et a/, 1 992), a nuclear receptor for which 
9-cis re tinoic ac id (9 cRA) is the natural ligand (AlJenby et al, 1993). 
To make this pic ture even more complex, VDR can also modulate 
tran scription as a homodimer or as a he terodimer with other 
nu clear receptors (Carlberg, :1.996). In addition, VD (and other 
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that retinoic acid opposed VD-induced accumulation 
of transforming growth factor-/H. p21WAFl• and 
p271nPt. Finally, retinoic acid reduced VD-elicited 
hypophosphorylation of the retinoblastoma protein. 
AtRA at micromolar concentrations conversely po-
tentiated most of the aforementioned VD-dependent 
actions. In addition, atRA and 9cRA (but not VD) 
caused a rapid, sustained reduction ofRXRa protein. 
VD receptor protein was induced by VD regardless of 
the prese~ce of RA. In conclusion, RA modulates 
VD-dependent effects at different levels of keratino-
cyte proliferation. This could have implications for 
the use of combinations of both drugs for skin dis-
eases. Key words: ca.lcitriollretiuoids/cell cycleltrausfovmiug 
growtllfactor-beta. J Invest Dermatol 109:46-54, 1997 
steroids) can also influence cellular fu nction via a nontranscrip-
tiona l, nongenomic pathway (BouilJon el a/, 1995). 
Retinoids and VD have a large array of effects on almo ·t every 
ce ll type studied (Bouillon et at, 1995), including epidermal kera-
tinocytes (B ikle ~nd Pillai, 1993) . Their profound effects on epider-
mal proliferation and differentiation led to the successful therapeu-
tic use of retinoids and VD analogs for the hyper-proliferative skin 
disease psoriasis (Kragballe, 1992) and for congenital ichthyosis 
(Lucker et a/, 1994). Retinoic acid (RA) is mainly known as a 
positive regulator of keratinocyte growth (Eiclu1er, 1986), but it 
can also ha-ve modulating efrects depending on donor age (Varani et 
a/, 1994) or culture conditions (Tong eta/, 1988), in a way reversing 
the proliferation rate . For VD, primarily dose-dependent anti-
prolifemtive actions have been established (Bikle and Pillai, 1993), 
although recently modulating effects were also reported (pro-
proliferative for cells committed to differentiate) (Gniadecki, 1996) . 
The molec11lar mechanism of th e anti-proliferative effect of VD 
in keratinocytes is only partly understood: it includes induction of 
the potent negative growth regulator transform.ing growth factor 
(TGF)-/31 (Kim et a/, 1992), suppression of the proto-oncogene 
c-myc (Matsumoto et al, 1990), and dephosphorylation of the 
retinoblastoma protein (Kobayashi et a/, 1993). It remains uncl ear, 
however, how VD affects other ceil cycle-regulating protei11s such 
as the cyclins, the cyclin-dependent kinases, and the cyclin-depen-
dent kinase inhibitors (Cdkfs) (Weinberg, 1995). 
In view of the similarities between VD and RA in (i) their 
molecular mechanism of action via nuclear receptors that het-
erod.imerize with RXIt, (ii) the spectrmn of skin disease s for which 
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their therapeutic efficacy has been demo n str ated, and (iii) the ir 
potent, som etimes modulating action o n keratinocyte proliferation, 
w e decide d to study the inte raction of both steroids o n human 
epide rmal keratinocyte prolifer ation. T h e e ffects of atRA, 9cRA, 
VD, and their combination were studie d o n DNA synthesis, on 
cell-cycl e distribution, and on diffe ren t aspects of their possible 
molec ular m echanism of action (VDR and RXRa expression, 
TGF-/31 expression, cell-cycle regulation , express ion of C dkls 
pl5 1NK 4 u, p21 WAF I. C ll ' l and p27K1" 1, phosphorylation status of 
retinoblastoma pmte in , and exp1·ession of c-myc and p53). 
MATERIALS AND METHODS 
Cell Culture Normal human epidermal keratinocytes were isolated f:i·o m 
foreskins of young donors (less than 6 y) as desuibed (Kitano and Okada , 
I 983) . Keratinocytcs were grown in Keratinocyte Serum Free Medium 
(GIBCO fiRL. Gaithersburg, MD) with a calcium concentration of 0.09 
mM and supplemented with 50 p..g of bovin e pitu itary exlTact per ml and 5 
ng of human epidermal growth fi1ctor 1-51 per 111! (GlfiCO BR.L). T hird-
or fourth-passage cells were used. For experiments, the same medium was 
used without insulin, thyroid hormone , and hyd rocortisone because higher 
VD anti-pro li fe rati ve activ ity was described in the absence of insu.l in (Chen 
el nl, 1995). VD, 9cRA , and atRA were added f:i·om stock so lutions oCI mg 
per ml in abso lute e thano l. Vehicle concentrations never exceeded 0.1 '% 
(vo l/ vol) and were kept lower than 0.03% for investigation of p21 WAF < 
because of its induction by ethanol 0.1'%. VD and 9cK A were a gift from Dr. 
Uskokovic (Hoffman-La Roche. Nutley, NJ); 25-(0H)-vitamin D3 and 
atRA were purchased from Sigma Chemical Co. (St. Louis , MO). 
[
3li]Thyinidine Incorporation Keratinocytes were seeded in a micro-
plate at a density of 5000 per well. One day later, the cells were treated witl1 
active products or vehicle (six replicates per condition). At 72 h after 
addition of VD, 1 p..Ci of [mcthyl- 3 H]thymidine (35 C i/ mmol; JCN 
Biomedicals, Costa Mesa, CA) was added to each well in fres h medium. 
After incubation for 3 h, the ce ll s were harvested semi-automatica lly 
(Filtermate Universal Harvester; Packard Instrument Company, Meriden, 
CT) on micwplates with filters, which retain only incorpora ted thymidine 
(GF/C filter; Packard Instrument Company), and were counted automati-
ca lly using a microplate scintillation counter (Topcoun t; Packard Instru-
ment Company). 
Cell-Cycle Analysis A tot~ ! of 250 ,000 keratinocytes were grown in 
60-mm dishes and treated with VD/ R.A (RA added 6 h before VD) . Cells 
were trypsinized after 72 h, washed twice in phosphate-buffered saline, 
fixed overnight in e thanol 70% at 4°C , washed twice in phosphate-buffered 
sa line-Tween 20 (0.05%), and incubated for 1 h at room temperature in 
phosphate-buffered sa line containing 10 p..g ofpropidium iodide per ml and 
20 p..g of l~asc A per mi. T he ceLl-cycle state was analyzed with FACSort 
(Becton Dickinson , .Lincoln Park, NJ) in the Cell Fit program . 
RNA Isolation and Northern Blot Analysis A total of 1 O'' cells were 
seeded into 1 00-mm dishes. Twenty-four hours later. R.A / VD were added 
simultaneously in fresh medium. Tota l cellular RNA was prepared by lysing 
the cells in cold g uanidine isothiocyanate buffer, followed by ultracentri f-
ugation on a cesium ch.l oride gradient. T otal RNA (15 p..g) was fractionated 
by forma ldehyde I% agarose gel dectrophoresis, blotted to a nylon 
membrane (HybQnd N ; Am etsham Corp. , Arlington H eights, IL) , and fixed 
by ul trav iolet cross-linking. Prehybridization and hybridization were per-
formed in 50% form amide; SX Denhardt's so lu tion ; 6 X sodium citrate/ 
chJoride buffer; 0.1 o;., sodium dodecyl sulf.1te; 50 mM sodium phosphate, pH 
7.0; and denatured herring sperm DNA (200 p..g per ml) at 42°C. DNA 
probes were labeled with a 3 2P-dCTP (Amersham Corp.) by random 
primin g; (O ligo labeling Kit; Pharri1acia Biotech Inc., Piscataway, NJ) . T he 
blots were washed under increasingly stringent conditions (last step in 0.1 X 
sodium citra te/chloride buffer; 0.1 %, sodium dodecyl sulfate) and autora-
diographed . The DNA probes used were: a 2.1 -kb human WAF1 eD NA 
f:i:ag;m ent (El-D eiry e/ a/, 1993) . a 2.1-kb human TGF-{31 eDNA (American 
Type C ulture Collection, Rockvi lle, MD) , a 0.479-kb human c-myc probe 
prepared with a reverse transcriptase polymerase chain reaction am plimer 
sec according to the supplier (Ciontech Laboratories Jnc., Palo Alto, CA ), a 
2. 1-kb human VDR. eDNA (American Type C ulture Collection) and a 
2-kb human p15 1NO< ·IU eDNA (Hannon and ficach, 1994). For veriftcation 
of even loading, we used the glyccraldchyde-3-phosphate dehydrogenase 
probe . 
Western Blot Analysis Cells were grown and treated as for Northern 
blo t analysis (simultaneous addition of VD/ H ..A, except for experiments 
determining the retinobhtstoma phosphorylation status, in which RA was 
added 6 h before VD) . T he keratinocytes were scraped in lysis buffer (150 
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mM NaCI. 50 mM Tt;s-f-IC I. pH 8.0. 5 m M ethylenediamine tetraacctic 
acid , 1% Nonidet P-40) containing 1 mM phenylmetJ,ylsulfonyl flu oride, I 0 
p..g leupeptin per ml , 10 p..g aprotin in per ml , and 1 p..g antipain per mi. 
Protein concen tration \vas dc te nn incd usin g the BCA Protein Assay l::t.c-
agent (Pierce C hemical Company, Rockford , IL). The extracts were mixed 
wi th an equal volume of sample buffer 2 X (1 25 mM Tris, pH 6.8. 20'% 
glycerol, 10% {3-mcrcaptocthanol. 4% sodium dodecyl sul fate) and resolved 
by sodium dodecyl sulfa te-po lyacrylamide gel electwphoresis, fo llowed by 
wet electrotransfer onto 1-!ybond-C Super membrane (Am ersham Corp.) . 
Blocking was performed in 5% nonfitt dry milk in phosphate-buffered 
sa line- Twcei1 20 (0 .1 'Yo) fo r at least I h at 20°C . T he membrane was 
incubated overnight at 4°C with the primary an tibody. washed. and 
incubated fo r 1-2 h at 20°C with the peroxidase-conjugated secondary 
antibody. Protein bands were visua lized usiug euhanced chemiluminescence 
as described by the supplier (Amcrsham Corp .). The primary antibodies 
used were: chicken anti-TGF-{31 (R&D Systems, Minneapolis. MN). 
recognizing _the TGF- {3 '1 precursor protein (Kim c/ nl, 1996); monoclonal 
anti-p2l \VA l· I (Oncogene Science Inc., Cambridge, MA) , visualizing p21 
prote in as a doublet (Li c/ nl. 1996): monoclonal anti-retinoblastoma gene 
protein and rabbit anti-p53 (Novocastra Laboratories Ltd. , Newcastle upon 
Tync, U .K.); rabbi t anti-p27 and rabbi t anti-R.XRa (Santa C ruz Diotcch-
nology, Santa Cruz. CA) ; and monoclonal anti-VDR (Dame et nl, "1986). 
Equal loading of proteins was assessed with a monoclonal anti-{3-actin 
antibody (Sigma·C hemical Co .) . Secondary antibodies included peroxidase-
conjugated rabbit anti-chicken (Sigma Chemical Co.) a.11d goat anti-r;1bbit 
and rabbit anti-inouse (Dako A/ S, Glostrup . Denm ark) . Q uantification of 
bands was performed using a laser densitom etric scanner (Pharmacia 
fi iotcch Inc.) ." 
Statistics We used Student's t test for unpaired observa tions to evaluate 
the data from ['H]thymidine incorporation and cell-cycle analysis. 
RESULTS 
RA Modulates VD-Induced Inhibition of ['H]Thymidine 
Incorporation in a Concentration-, Time-, a nd RA Isomer-
Dependent Way E xposure of pre- confluent ke ratin ocytes to 
VD for 72 h decreased thymidine incorporation at concentrations 
hig he r tb a.n 10 - 10 M, with hal f-maximal e ffe cts at 10 - R M and 
complete growth arrest at 10- 6 M (F ig 1). AtRA slig htly stimulated 
DNA synthesis (20'Yo) at concen tratio n s less than 1.0 - 7 M , w hereas 
high e r con centrations r esulte d in inhibitio n (5 X 1 o- 7 M ca used 
50% a nd 10 - 6 M ca used 75% of inhibiti o n) ; 9cRA wa s stimulatory 
for con centra tion s up to 1 o- (, M and inhibite d growth at highe r 
doses (da ta no t shown) . Beca use RA tends to h ave modula ting 
e ffec ts o n k e ratinocyte pro liferation (stimu lation of slowly g rowin g 
and inhibition of rapidly g rowin g cells) (Tong et a/, 1988), we 
added R A 6 h after VD. Unde r these conditions, we noticed 
additive effects at VD con cen tratio n s of Jess than 1 o- H M (Fig 1). 
At high er VD con centrations , however, atRA at concen trations less 
than 1 o- n M and 9cRA signifi cantly atte nua ted the VD e ffect (Fig 
1a-j). Surprisingly, even som e (b y the m selves) inJ1ibitory con cen-
trations of RA partly protected aga in st th e VD effects (Fig 1a for 
atR.A 2.5 X 10- 7 M). At a pharmacologic concentration of t O- r' M, 
however (Due ll eta/, 1992), atRA cleady poten tiated th e VD action 
(Fig la), whe reas 9cRA sti ll exhibite d an tagonism at this con ccn-
tJ:ation (Fig ld). In addition, w e inves tigated w h ethe r th e addition 
ofRA 16 h b efore o r after VD influe n ced its interaction w ith VD . 
The effects of individual RA treatment did n ot ch an ge in b oth cases 
(data not shown). We noticed th at t he RA/ VD an tagonism was far 
more pronounced with pre-incuba tion of RA and wa s not limite d 
anymore to VD con centrations of m o re than 10- 8 M (Fig 2). T he 
enhan ciJlg e ffect of atRA 10 - r, M was also Jess pronounce d (Fig 2). 
Subpbarmacologic Concentrations of Retinoids Attenuate 
VD-Induced G1 Arrest and Retinoblastoma Dephosphory-
lation Keratinocytes treated for 72 h with VD 10 - 7 M accu mu-
lated in G1 , with a con con"titant sh arp d ecLine of S-phase cells and 
no significa n t change of cells in G2 + M phase (Table I). 
Co-treatJnent with atR.A 10- 7 M or 9cRA aga in attenuate d th ese 
c ha nges, whereas atRA to - r. M m<~intained th em. In parallel , 
VO-treate d keratinocyte~ (10 - 7 M for 48 h) exhibite d marked 
deph osphory lation of the retin o blasto m a pro tein (Fig 3), charac-
teristic ofGl accumulation. T his effect was aJso inhibite d by atRA 
10- 7 M and YcRA 10 - 6 M and was accen tuate d b y atRA 10 - 6 M . 
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Figure 1. Rctinoids modulate VD-dcpendent inhibition of DNA 
synthesis. Keratinocytes grown in microplates were treated for 72 h with 
VD :!: RA (addition 6 h after VD). Experiments for (3H]thymidine 
incorporation were carried out as described. Results are expressed as 
percentage of vehkle controls (23,000 cpm) as mean of six replica tes ± 
SEM. e, VD; 0 , VD + RA (except VD + atRA 10- 6 M, .A); •• RA control 
(except atRA 10- 6 M, 'f') . (a) Interaction of VD with atRA 10- 6 M or 
2.5 X 10- 7 M; (b), (c), (d), (c) , n11d (f) refer to the combination of VD and 
atR.A 10- 7 M, atRA 10- 8 M, 9cRA 10- 6 M, 9cRA 10- 7 M, and 9cR.A 
10- 8 M, respectively. Under the conditions in which RA coLmteracted the 
VD efl:ect, statistical analysis (Student's t test) was performed: *, p < 0.05; 
** , p < 0.01; *** , p < 0.001 for comparison of (RA + VD) with VD alone. 
The retinoids alone had only limited effects. Thus, VD prevents 
retinoblastorna phosphorylation and G1-S transition, effects that are 
diminished by RA (except atRA 10 - 6 M). 
VD Induces TGF-/31, p21WAFI, and p27KIPt in Keratino-
cytes, Effects That Are Modulated by RA The TGF-{31 
transcript-(2.5 kb) w as induced 2- to 3-fold by VD 10- 7 M for 1 or 
2 d (Fig 4). This effect was almost completely suppressed by 
sinmltaneous incubation with atRA 10- 7 M (Fig 4), 9cRA 10- 6 M, 
or atRA 10- 6 M (Fig 5). The 54-kDa TGF-{31 precursor protein 
also increased by 70% and 100% with VD 10 - 7 M for 48 h (Fig 6) 
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or 72 h (data not shown), an action that was opposed by RA at all 
tested concentrations . 
P21 mRNA was induced about 2- fold by VD 10 - 7 M for 24 h 
(Fig 5) and remained elevated at 48 h (data not shown). AtRA 
10- 7 M or 9cRA 1.0 - 6 M stro11gly reduced this induction, whereas 
atRA 10- 6 M maintained it (Fig 5). AtRA 10- 6 M doubled p21 
mRNA at tlus time, but 9cRA 10- 6 M or atRA 10 - 7 M had no 
effect. Protein levels of p21 exhibited a pattern comparable to RNA 
levels: a 2.1- fold induction by VD 10 - 7 M for 48 h, din1inislung to 
1.5 and 1.4 by atRA 10- 7 M and 9cRA 10- 6 M (Fig 7). AtRA 
10- 6 M induced p21 and maintained the VD effect. Earlier time 
points revealed a modest 40% induction ofp21 protein by VD 10 - 7 
M after 28 h and no induction after 7 h (data not shown) . No 
changes of p53 protein levels w ere observed 7, 28, or 48 b after 
VD/RA treatment (data not shown). 
P27KtPI protei11 was induced 2.4 times by VD for 48 h (Fig 7). 
T his effect was also antagonized by RA: 9cRA 10- 6 M or atRA 
10- 7 or 10- r. M brought it to 1.8 times the control level (Fig 7). 
T hus, atRA J0 - 6 M did not maintain the VD effect as for p21 and 
did not induce p27 by itself (Fig 7). Induction of p27 protein was 
not observed after 7 or 28 h ofVD treatment (data not shown) . In 
contrast to leukemia cell s (Liu et al, 1996b) , keratinocytes did not 
accumulate p15 1N K 4B mRNA after treatment with VD 10 - 7 M for 
24 h (data not shown). 
The 2.1-kb c-mJ'C rnRNA was downregulated by 10- 7 M VD in 
a time-dependent way: after 24 h and 55 h , it fell to 49 .6% and 
18.3°/.,, respectively, of control levels (Fig 4). Co-treatment with 
atRA 10 - 7 M slightly attenuated this effect to 53 .8% and 24 .5%, 
respectively (Fig 4) . 
Retinoids Markedly Suppress RXRa Protein Levels; VD 
Induces VDR Protein AtRA and VD slightly decreased RXR.a 
mRNA (5.6 kb) (Fig 4). Immunoblot, however, revealed a quick 
and concentration- dependent decrease of RXRa proteil1 levels by 
RA. AtRA 10 - 6 M and 9cRA 10 - 6 M (alone or in com bination 
with VD) diminished RXRa protell-1. by a spectacular 5 to 7 times 
after 48 h (Fig 6). These changes could be observed as early as 4 h 
after RA treatment (data not shown). Lower RA concentrations 
had similar but less pronounced effects. RA rriay accelerate RXI~a 
protein degradation because the quick fall of R.XRa protein levels 
was accompanied by only minor changes of mRNA. 
T he 4.4-kb VDR mRNA decreased 2- and 3-fold after 1 or 2 d 
of VD exposure (Fig 4). Co- treatment with RA brought VDR 
mRNA nearly back to control levels. VDR protein levels con-
trasted with the observed mRNA levels: VD il1duced its receptor 
proteil1 by at least 2 times after 3, 7, 28 (data not shown), and 48 h 
of treatment (Fig 6), regardless of the presence of RA. The 
reduction ofVDR mH.NA together with il1ereased proteil1 levels-
probably by ligand-induced protein stabilization (Van den Bemd et 
al, 1996)-il1dicate that VDR is susceptible to complex autoregu-
lation in keratinocytes. 
DISCUSSION 
The r evealing ofVD signaling pathways, il1 wluch heterodilneriza-
tion ofVDR with retinoid receptors plays a key role (Kliewer et al, 
1992; Carlberg and Saurat, 1996), provides a firm theoretical basis 
to study VD/RA combinations in target cells. During past years, 
combinations of reti.noids and VD have been assessed in many 
experimental systems, with reports of both synergistic (Koga and 
Sutherland, 1991; D efacque et al, 1994) and antagonistic effects 
(Oberg et a/, 1993) . Apart from an abstract,1 however, the com-
bined effects of RA/VD on proliferation in cultured keratinocytes 
have not been described previously . T herefore, we studied the 
combined action of VD and RA in rapidly proliferating kerati.no-
cytes derived from young donors and cultured under low-calcium 
conditions. W e chose tlus model because cul tured keratinocytes 
'Gibson DFC and Bikle DD. Interactions of 1,25(0HlzD3 and all-trn11s 
retinoic acid in regulating proliferation and differentiation of normal and 
transformed keratinocytes. J l1111est D ermntol 104:613, 1995 (abstr). 
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reflect the hyper-proliferative state of psoriasis (Weiss el a/, 1984), 
a disease for which VD analogs and retinoids have proven to be 
efficacious drugs. Our investigation clearly confirmed that VD is a 
potent anti-proliferative agent i.n cultured keratinocytes (Matsumo-
to et al, 1990), as m anifested by a concentration- dependent reduc-
tion of DNA synthesis and G1 arrest. This anti-proliferative effect 
could be modulated by RAin both ways: atRA 10 - 6 M potentiated 
the VD action , whereas 9cRA or lower concentrations of atl:t.A 
counteracted it. In addition, we showed that VD-induced growth 
arrest was accompanied not only by accumulation of TGF-{H and 
dephosphorylated retinoblas toma protein, but also by induction of 
the Cdkls p21 WAFt . CIPl and p27'0~''. R etinoid modulation seems 
to occur at all of these levels (Fig Sa). 
TGF-,81, which is itself a very potent growth inhibitor of 
epidermal keratinocytes (Massague et al, 1992), is thought to 
mediate the VD anti-proliferative effect to a large extent (Kim et a/, 
1992). As for VD, dephosphorylation of retinoblastoma protein and 
suppression of c-myc expression are among TGF-,81 ' s mechanisms 
ofaction (Mi.inger eta /, 1992). Induction of the Cdkls p21WAFt. 
CIPt (Datto eta/, 1995), p27 KIPI (Polyak et a/, 1994), and p15INK4 J3 
(Hannon and Beach, 1994) is probably involved in these events . 
We clearly confirmed VD-dependent TGF-,131 induction in kera-
tinocytes. Moreover, we demonstrated that RA blocked tlus induc-
tion as in breast cancet· cells (Koli and Keski-Oja, 1996), thus 
withdrawing the cells from this growth- inhibitory cytokine. 
Table I. Retinoids Modulate VD- Induced Gl Arrest" 
Treatment G1 s G2 + M 
Control 50.3 :!:: 1.l 26 .7 :!:: 1.0 23.0 :!:: 1.0 
YO 10- 7 M 71.7 :!: 0.71' 5.2 :!:: 0.3 1' 23.1 :!:: 0.7 
VD 10- 7 M + 
atRA 10- 6 M 73.3 :!:: 0.61' 3.8 :t o.s~> 22.9 :!:: 0.9 
YO 10- 7 M + 
atRA 10- 7 M 65.6 :!:: 1.21'" 11.3 :!:: 1.41" 23.1 :!:: 1.8 
VD 10- 7 M + 
9cRA 10- 6 M 62.6 :!:: 1.41" 14.4 :!:: 2.7bc 23.0 :!:: 1.6 
VD 10- 7 M + 
9cRA 10 - 7 M 64.5 :!:: 1.51" 12.5 :!:: 2.21" 23 .1 :!:: 1.5 
atRA 10- 6 M 64.1 :!:: 1.26' 12.5 :!:: 1.36' 23.4 :!:: 1.4 
atR.A 10- 7 M 53.6 :!:: 1.5 23.5 :!:: 1.9 22.9 :!:: ~ .2 
9cR.A 10- 6 M 52.9 :!:: 1.0 23.2 :!:: 1.6 23.9 :!:: 1.7 
9cRA 10- 7 M 52.8 :!:: 2.1 23.8 :!:: 1.3 23.4 :!:: 1.7 
,. Kcratinocytes were grown for. 48 h in the presence ofVD/ RA , trypsinized , fixed, 
and stained with propidium iodjdc to invcstig;1te rbe ccl.l cycle by flow cytomctry. Dara 
represent the mean of f1ve replicates .± SEM a_nd arc expressed as percentages. 
" Sta tistically signi fica nt difference (p < 0.001) in comparison with contro l group. 
' Statisti cally significant differen ce (p < 0.001) in comparison with VD 10- 7 M 
group . 
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Figure 2. RA pre-incubation enhances its 
antagonistic effect on VD. [3H]thymidine 
incorporation was assessed for the combination 
ofYD (72 h) and R.A (added 16 h before or after 
VD) and was plotted as for Fig 1. e, VD; 0 , 
VO + RA 16 h after; 0, VD + RA 16 h before . 
The interaction ofVO with atRA 10- 6 M, atR.A 
1 o- 7 M. and 9cR.A 10- 6 M is shown as indi-
cated. *, p < 0.05; **, p < 0.01; *** , p < 0.001 
by Student's t test for comparison of (RA + 
VD) with VD alone; $, p < 0.05; $$, p < 0.01; 
$$$, p < 0.001 for comparison of [VD + R.A 
(pre-incubation)] and [VD + RA (post-incuba-
tion)]. 
In its function as Cdkl, p21WAFl , CIPl negatively regulates 
cell- cycle progression (Harper et a/, 1993) . It is induced by wild-
type p53 (El-Deiry et al, 1993) and by TGF-,B (Datto el al, 1995). In 
leukemia cells, VD was shown to induce p21 (Liu et al , 1996b; 
W ang et al, 1996), and recently a fun ctional vitamin D response 
element has been identified in the promoter of the p21 gene (Liu el 
al, 1996b). We demonstrated VD-dependent induction ofp21 in 
cultured keratinocytes with a m arked increase of mRNA and 
protein after 1 and 2 d, respectively. AtRA 10- 7 M and 9cRA 10 - 6 
M antagonized tllis induction, whereas atl:t.A 10 - 6 M maintained it. 
These data are in total agreement with the effects of RA/VD on 
thynlidine incorporation, cell- cycle distribution, and retinoblas-
toma phosphorylation status: VD induces p21, which inlubits 
cyclin-cycl:in- dependent kinase complexes n ecessary for retiuo-
blastoma phosphorylation. AtRA 10- 6 M maintains tl1e p21 induc-
tion, keeping retinoblastoma dephosphorylated and preventing 
G1 - S transition, with G1 arrest and inhibition of DNA synthesis 
(Weinberg, 1995) , whereas atRA 10- 7 M ru1d 9cRA 10 - 6 M 
ru1tagmuze p21 induction ru1d tl1e subsequent events. It remains to 
be investigated whether these effects are mediated by direct VD-
dependent transcription of the p21 gene (Lin et a/ , 1996b) or by 
intermediaries such as TGF- ,131 (Datto eta!, 1995) or p53 (El-D eiry 
et a/, 1993). The relatively late induction ofp21 could point to the 
involvem ent of the .named mediators. Induction of p 21, however, 
did not totally parallel that of TGF- {31 (especially for VD + atRA 
10 - 6 M) , but this discrepancy may be explained by direct RAR-
~ ~ ~ 
~ ,._ '9 ~ ~ 
~ i ~ u 
"' 
m 
+ + + :::; :::; :::; 
:::; :::; :::; :::; ~ ~ '9 i ~ ~ 
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";- ~ ~ ~ ~ ~ i q: 0 0 0 ~ 0:: 0 u > > > .. m ppRb 
pRb~ ~ .,:::.__ - ~ 
67.9% 27.7% 17.1% 37.3% 42.6% 58.3% 74.0"/o 66.6% ppRh 
32.1% 72.3% 82.9% 62.7% 57.4% 41.7% 36.0% 33 .4% pRh 
Figure 3. RA modulates VD-dependcnt retinoblastoma dephos-
phorylation. Western blot analysis was performed (as described in M ate-
rials aud Mctilods) to determine the retinoblastoma phosphorylation status of 
keratinocytes treated for 48 h with VD/RA. One representative experiment 
of three is shown. PpRb and pRb designate hyper- and hypophosphorylated 
forms of the protein, as visualized by western analysis and quantified by laser 
densitometry. 
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mediated transcriptio n ofp21 (Liu el a/, 1996a). Finally, p53 protein 
levels did not chan ge duri11g VD treatrnenl , 'Jut thi s does not tota lly 
exclude a p53-dependen t pathway (Weinberg el a/, 1995). 
W e also demonstrated clear induction of the p21-related Cdkl 
p27 K11' 1 (Polyak et a/, 1994) 48 h after VD treatment, as described 
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Figure 4. RA suppresses VD-mediated TGF-/31 mRNA induction. 
Northern blot analysis was performed with 15 p.g of tota l .RNA of 
kcratinocytes treated for 24 or 55 h with RA/VD. This was followed by 
hybridiza tion with probes for TGF-{31. c-III )'C, VDR, RX.Ra, and glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH). 13.1ots were scanned and 
then plotted afte r normalization for glyceraldehyde-3-phosphate dehydro-
genase va lues . 
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F igure 5. RA modulates VD-dependent induction of p21W/\Fl 
mRNA. Total RNA (15 p.g) ofkeratinocytes treated for 24 h with VD/ RA 
was subjected to Northern analysis. T he blot was hybridized with probes 
for TGF-{31, p21 W A F '. and glyccraldehyde-3-phosphatc dehydrogenase 
(GAPDH). Norma lized densitometric data are also shown . 
in leukemia cells (Liu eta/, 1996b; Wang et al, 1996). T his effect 
wa s also attenu ated by RA. We could not demonstrate differential 
actions for atRA 10- 6 M and 9cRA/atl"V\ 10- 7 M, however , as 
was the case for p21. The indu ction ofp27 was strikin gly parallel to 
that ofTGF-/31 , suggestin g a medi atin g role for TGF-/31 (Polyak el 
a/, 1994). 
To summarize, atRA at subph ann acologic co ncentra tions and 
9cR.A attenuate VD-dependent inhibition of keratinocyte prolifer-
ation , especially w hen addition ofl"V\ precedes that ofVD, w hereas 
10- r, M atRA potentiates this effect. Although TGF-/31, p21 , p27, 
and retinoblastoma pro te in are ca ndidate mediators of this in terac-
tion (Fig Sa), their express ion o r function is modified only at a 
rather late stage (Table II). T hercfcre , we need to look at a m o re 
upstream le vel to o btain m ore .insight abo ut the ea rl y sequences of 
the VD/RA in teraction . T he observed antagonism between RA 
and VD m ay be explained by the folJowing h ypothetical m echa-
nisms (Fig 8/1). (i) AtR.A has been reported to inhibit VD-VDR. 
bindin g in keratinocytes (Fogh cl a/ , 1996) and in breast cancer cells 
(Koga and Sutherland , 1991 ). (ii) 24-hydroxylase, a key cataboli c 
enzyme for VD, is induced via an RXR.-dependent pathway i11 vivo 
(AJJegretto et al, 1995) and in cu ltured colo n cancer cells (Kane el 
al, 1996). (iii) By a process ofligand-induced squelchin g. RXJ'l._ can 
be sequestered from VDR-R.X.R by engagem ent in other nuclear 
receptor dim ers (in tbjs case, RA-indu ced RXR-R.XR. and RAR-
RXR). Indeed, VD genomic sign alin g is regulated by a complex 
con trol system depending on the availab ility of nucl ear recepto rs, 
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Figure 6. RA markedly decreases RXRa protein; VD induces VDR 
protein. Western ana lysis was performed on cells treated for 48 h w ith 
R.A/VD to detect TGF-/31. precursor protein, RXRa, VD.R, and /3-actin. 
Densitometric data normalized for /3-actin were plotted. 
the presence of steroid ligand, and the structure of target gene 
response elements (Williams, 1994) . Because RXR is the central 
promiscuous nuclear receptor partner for heterodimerization 
(Green, 1993), its availability is crucial. When RXR is present in 
excess, its ligand 9cRA will potentiate transcription by RXR-VDR 
beterodimers (Schrader et nl, 1995; Lemon and Freedman, 1996). 
Conversely, when RXR availability is less pronounced, by low 
expression or by involvement in too many signaling pathways , 
RXR homodimers induced by 9cRA (Zhang et nl, 1992) or 
RXR-containing he terodimers (Barettino el nl, 1993) can draw 
R:Xl'l... away from its heterodimer partner. This ligand-induced 
squelching is suggested not only for VD signaling (Macdonald et nl, 
1993; C heskis and Freedman , 1994), but also for T3 receptor 
(Lehman et a/, 1993) and RAR-mediated signaling (Hembree et a/, 
1996). (iv) Apart from ligand-induced squelching, RAR-RXR can 
compete with VDR-RXR for binding to shared DNA response 
elements (Cao et al, 1996). 
In epidermal keratinocytes, R:X:Ra accounts for most of the 
RXR (Fisher et. a/, 1994), and RX.Ra-VDR heterodimers represent 
the main VD genom.ic signaling pathway (Kang eta/, 1996). We 
observed that RA red uced the level of lURa protein in a quick 
and dramatic way, thus facilitating ligand-induced squelching of 
RXR. Conversely, elevated R:X:Ra protein was reported with 
RA/VD synergism in leukemia cells (Defacque eta/, 1994). This 
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strengthens the idea that the availability of functional RXR is 
crucial to exert the effects of its partner receptor (Cliffm'd ct nl, 
1996; Feng eta/, 1997) . Tissue-specific regulation and expression of 
RXR and other nuclear receptors could therefore clarify somewhat 
the paradoxical data on combined RA/VD action in different 
systems. In this context, cell type- specific regulation of VD 24-
hydro~:ylase may also play a role (Kane ct nl, 1996) . 
It was reported that synergy between VD ~md RA occmred only 
when VD was added before RA (Taimi et nl, 1991) . Others showed 
that atRA antagonized VD function only when added before VD 
(Oberg et al, 1993). Likewise, we demonstrated that pre- incubation 
with RA enhan ced its antagonism to VD. Logically, RA will inhibit 
VD-VDR binding more readily when pre-incubato:;d. In addition, 
•·etinoid-induced VD catabolism needs time for RXR-mediated 
upregulation of24-hydro,.:ylase . Finally, lowering ofRXRa levels 
by RA facilitates ligand-induced squelching of R:X:Ra. Another 
remarkable finding in our study is that RA/VD antagonism was 
most pronotmced at rather high VD concentrations (as shown by 
thymidine incorporation experiments) . This could be explained by 
the fi.nding that low VD concentrations mainly activate VDR 
homodimers and not VDR-RXR heterodimers, which are suscep-
tible to retinoid modulation (Carlberg et nl, 1994). 
Unlike R:X:Ra, the expression of VDR did not seem to be 
ca usally involved in the observed RA/VD interaction. Indeed, the 
VD-induced ·increase ofVDR protein (probably by ligand-induced 
stabilization) was not influenced by RA even though RA attenu-
ated the VD-dependent decrease of VDR mRNA. This indicates 
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Figure 7 . Upregulation of p21 WAF I and p27KJPI protein by VD is 
modulated by retinoids. Protein extracts ofkeratinocytes ipcubated with 
VD/RA for 48 h were subjected to Westem ana lysis. Antibodies directed to 
p21, p27, and /3-actin were used. Normalized densitometric data are also 
plotted. 
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a b 
VO cataboliles 
Figure 8. Hypothetical model for R.A/VD in-
teraction in keratinocytes. (n) VD induces the 
growth-inhibitory cytokine TCF-{31 and (directly 
or indirectl y) p21 W AI' I and p27""' 1, which inhibit 
phosphorylation of retinoblastoma, arresting the 
cells in C1. Both 9cRA and atl~ (possibly via 
isomerization to 9cRA) antagonize the VD action, 
mostly via RJCR-dependcnt effects (fo r explanation 
ofRA/VD antagonism, designated by'' *," sec (b). 
High concentrations of atRA (1 0- 6 M). however, 
lead to predominant activation of l~fl and en-
han ce the VD anti-proliferative etfect via ll_AR-
dcpendcnr upregulntion of p21 and/ or transrcpres-
sion of AP1. (b) Retinoid antagonism of VD action 
may be exp.lained by the fo llowing mechanisms: (i) 
inhibition of VD-VDR binding by atl~; (ii) 
R.Xfl-mcdiated induction of the VD catabolic en-
zyme 24-hydroxylasc; (iii) squelching of RXR 
from VDR-RXR to retinoid-induced RXR-R.Xfl 
or I~R-RX.R, an effect that is fa cili tated by 
R.A-mcdiatcd suppression of RXR; and (iv) com-
petition between I~R-R.XR and VDR.-IUCR for 
binding to shared DNA response elements. Sec 
Disc11ssio11 for further details and references. 
VD 9cRA -- a!RA 
~--- -. TGF~" ~ ~ ~ RXR 
Prevention of retinoblastoma phosphorylation VDR-VDR VDR-RXR RAR-RXR RXR-RXR 
that RA may be more effective in inte rferiJlg with VD-dependent 
transcription (affecting VDR mRNA) than with VD-VDR binding 
(affecting VDR protein) . 
Another point to address is whether we ca n appeal to RXIl...-
dependent m echanism s (24-hydrm,)'lase induction and ligand-in-
duced sque lchin g ofRXR) for effects ofatRA, which h as no affinity 
for RXR (Allenby el al, 1993). Evidence of interconversion b e-
tween atRA (ligand for RAR) and 9cRA (ligand for RXR. and 
R.AR) ha s been found in many cellular systems, including kerati-
nocytes (Urbach and Rando, 1994; Xiao el a/, 1995; Duell 1'1 a/, 
1996). This makes it very difficult to distinguish between RAR-
and R.XR-depende t.tt pathways by using atRA and 9cRA. Yet o u r 
finding that 9cRA stiJJ opposed the VD effect at hig h concentra-
tions, whereas atRA showed a dua l response (antagonism at low 
lmd enhancement at high concentrations), suggests that an tagonism 
is an RXR-dependent event and enhan cement is an RAR-depen-
dent event. Indeed, the fact that epidermal RXR is 5 times m o re 
abundant than RAR (Fisher el a/, 1994) indi cates th at R.XR 
signaling predominates over that ofRAR. Moreove r, evidence has 
gt·own that RAR may direct keratinocytes to growth arrest and 
differentiation, whereas RXR. mediates the reverse actions 
(Aneskievich and Fuchs, 1992; Darwiche el a/, 1995; Saitou e/ a/, 
1 1/ 1 1 
interaction with DNA for transcriptional regulation 
1995). T his concept is further supported by the demonstration tbat 
two crucia l anti-pro liferative path ways depend on RAR (Fig Sa): 
F irst, the promote r of the p21 gene can be activated th ro u gh a 
retinoic acid response e le m ent (Liu e/ a/, 1996a); second, retinoid-
induced transrepression of transcription factor AP1 seems to depend 
on atRA and RAR (Fisher and Voorhees, 1996). We observed 
anti-pro li ferative ~ctivity and enhancement of the VD e[ect only 
with high pharmacologic concentrations of atRA, which a lso 
induced p2l in our cell s. T his indicates th at high doses of atRA 
activate m ainly RAR. Under these conditions, RXR. activation via 
isom ei·ized 9cRA probably cannot counte rbalance atRA and R..AR-
mediated e[ects anymore, which fma ll y res ults in enhancement of 
the VD efi:ect. 
In conclusion , RA modulates the anti.-pro li ferative efi:ect of VD 
in cu ltured keratinocytes: Pharmacologic concentrations of atRA 
enhance it, and lower con centrations of atRA and 9cRA antagon ize 
it. RA modulation of VD-induced TGF-/31, p21WAFI. CIPt, 
p27""' ' , and dep hosphorylation of retinoblas toma protein cou ld be 
involved in these events, together with a strong reduction of 
RXR.a prote in levels by RA. T h e observed interaction may have 
implications for combinations of retin o ids and vitamin D ana logs 
used for the treatment of skin diseases such as psoriasis. Ou r results 
Table II. RA Modulates the VD Anti-proliferative Effect in Keratinocytcs: Summary Table" 
O utcome 
DNA synthesis 72 h 
Cell-cycle status 72 h 
Retinoblastoma phosphorylation 48 It 
TGF-{31 mRNA 24 h or 55 h 
TC F-{31 precursor protein 48 h or 72 h 
p21 mRNA 24 h or 48 h 
p21 protein 48 h 
p27 protein 48 h 
c-myc mRNA 24 h or 55 h 
p15 mRNA 24 h or 55 h 
p53 protein 7 It to 48 h 
VDR mRNA 24 h or 55 h 
VDR protein 4 h to 48 h 
RXH.a mRNA 24 h or 55 h 
RJCRa protein 4 h to 48 h 
VD (10 - 7 M) 
Marked decrease 
C1 arrest 
Dcphosp l1 orylation 
luduction (2-3 x) 
Induction (2x) 
Induction (> 2x) 
Induction (> 2x) 
Induction (> 2x) 
Suppression (2-5x) 
Slight decrease 
No effect 
Suppression (2-3x) 
Induction (> 2x) 
Slight decrease 
No effect 
VD + RA 
+ atRA 1 o- r, M 
Not done 
Not done 
Decrease (5-7x) 
+ at!~ 10- 7 M 
or + 9cl~ 10- " M 
Decrease (2-7x) 
IV\ 
atl~ 10- ' ' M 
Decrease 
± G1 arrest 
± Dephosphorylation 
No effect 
No effect 
Induction (2x) 
Induction (2x) 
No effect 
Not done 
Not done 
No elfcct 
No effect 
No effect 
Decrease 
Decrease (5-7x) 
at!.<.A ·ro - 7 M 
or 9cl~ 10 - 6 M 
No effect 
No efrect 
No effect 
No clfcct 
No ell:ect 
No efFect 
No cflect 
No efl'cct 
Suppression 
Slight decrease 
No ctfcct 
No eff-ect 
No efl:ect 
Decrease 
Decrease (2-7x) 
'' Results of the (VD + l'lA) group arc expressed as compared with the VD group: 
modest cn h;m ccmcnl· o f the VD effect. 
designate :mtagonism, modcsr ant;lg:onistn, no efFect, enhan cement, and 
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suggest that high doses of RAR-activating retinoids probably will 
be needed to potentiate the therapeutic effect of VD. Preliminary 
studies with the combination ofRA/VD for psoriasis are consistent 
with this point of view (Carlberg and Saurat, 1996). 
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